Potential for 340B refunds for certain Genetech Drugs

HRSA and Genetech have announced some 340B covered entities may be eligible for a refund for certain Genetech drugs purchased in 2012. If you believe you’re impacted by this refund or have questions, contact Genetech at with the subject: “Attention: Recalculated 340B Ceiling Prices” byDecember 31, 2016.